🔬 Curious how cutting-edge cell culture technology is accelerating the path to curing human diseases? We're breaking down three powerful ways to work with Monomer Bio—from monitoring and data generation to full automation in your own lab. 🧬✨

💡 Investors want you to go all-in on software and growth, but the best founders know something different: risk management is everything. 📊

🔥 "Fundraising is just a tool" – This conversation challenges the Silicon Valley mindset that every company needs VC backing, even in capital-intensive industries like biotech 💊

Apple Podcasts: https://t.co/g7T1MFfcpW Spotify: https://t.co/ey9l1pFh3Y YouTube:

Head over to Apple Podcasts or Spotify for this episode and more stories only a biotech exec can tell! #biotechnology #lifesciences #podcast

Jimmy's journey reveals how staying anchored to a deeply personal mission—inspired by seeing his brother in an incubator—can guide every strategic decision from capital raising to product architecture.

– Why autonomous science will happen, drawing parallels to the once-impossible dream of autonomous vehicles

– Decision-making under uncertainty as a CEO, reframing constant worrying as strategic risk management – The "impedance mismatch" between founders who need to diversify and investors who want singular focus

In this episode, we cover: – Why fundraising is just one tool in the toolkit—not a requirement—and how services businesses can bootstrap biotech innovation – The decision to open Monomer's own lab to dogfood their software and let unscalable work inform scalable products

In part 4 of The Biotech Startups Podcast conversation with Monomer Bio CEO & Co-Founder, Jimmy Sastra, a central theme is building a company guided by purpose while navigating the complex realities of capital strategy, product development, and long-term vision.

"We gotta stay true to our mission... developing tools that explore the unknown universe of living cells. We innovate with the goal of curing human diseases, and we inspire the world by uncovering intricate details of how life works."

Discover how Monomer Bio cracked the code on one of cell culture's biggest challenges 🧬🔬 Stem cells are notoriously finicky and nearly impossible to scale—but what if robotics could change that? 🤖

🧬 Revolutionizing drug testing by scaling stem cell-derived disease models to reduce our reliance on animal testing—without replacing it entirely. 🔬✨ What breakthrough in lab-grown disease models would make you most excited about the future of medical research? 💭👇

From consulting to profitable startup 💡 These co-founders combined biotech, robotics, and software engineering to build Monomer—but their secret? Starting as consultants to learn the business first. 🚀

🤖 Discover how robotics and AI are revolutionizing cell culture automation—taking tedious lab work from manual to autonomous with real-time visibility and collaboration tools! 🔬✨ What's the biggest bottleneck in your lab that you wish could be automated? 💭👇 #LifeSciences

Apple Podcasts: https://t.co/g7T1MFfcpW Spotify: https://t.co/ey9l1pFh3Y YouTube:

Head over to Apple Podcasts or Spotify for this episode and more stories only a biotech exec can tell! #biotechnology #lifesciences #podcast

It's a masterclass in problem-first thinking and the strategic advantages of obsessing over customer pain points before jumping to solutions.

– The three-tiered go-to-market strategy: software-only monitoring, pilot projects in Monomer's lab, and fully automated robotic work cells to meet customers where they are

– Building multidisciplinary teams where trade-offs can be made across software, hardware, and biology—asking "do we solve this with different reagents or with a shaker?"